EP0133700A2 - Mehrschichtteststreifen zur Bestimmung von Analyten in flüssigen Testproben - Google Patents

Mehrschichtteststreifen zur Bestimmung von Analyten in flüssigen Testproben Download PDF

Info

Publication number
EP0133700A2
EP0133700A2 EP84109420A EP84109420A EP0133700A2 EP 0133700 A2 EP0133700 A2 EP 0133700A2 EP 84109420 A EP84109420 A EP 84109420A EP 84109420 A EP84109420 A EP 84109420A EP 0133700 A2 EP0133700 A2 EP 0133700A2
Authority
EP
European Patent Office
Prior art keywords
test device
layer
septum
layers
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP84109420A
Other languages
English (en)
French (fr)
Other versions
EP0133700A3 (de
Inventor
Richard Calvin Ebersole
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EIDP Inc
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Publication of EP0133700A2 publication Critical patent/EP0133700A2/de
Publication of EP0133700A3 publication Critical patent/EP0133700A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/525Multi-layer analytical elements
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/805Test papers

Definitions

  • This invention relates to an improved multilayered test device for detecting analytes in liquid test samples.
  • U.S. Patent 3.723.064. issued March 27, 1973 to Liotta describes a layered testing device for quantitatively determining the concentration of an analyte which includes a first or receiving layer impregnated with a chemical reagent for reaction with the analyte by which an end product is produced, a second or transmission layer to draw the end product through a porous membrane separating the first and second layers, and a third or indicator layer impregnated with reagents capable of reacting with the end product to provide a visual indication of the presence of the end product generated in layer one and reaching layer three.
  • the indicator layer can be adapted to be peeled off and saved to provide a permanent record of the test.
  • the porous membrane interposed between the first and second layers has regions of different permeability which permit passage of the end product according to the concentration of the analyte. Passage of fluid through the porous membrane is solely a function of concentration of the analyte and is not otherwise controllable.
  • U.S. Patent 4,166,093, issued August 28, 1979 to Smith-Lewis et al. describes an element for the analysis of liquids which contains a radiation-transmissive, detectable species migration-inhibiting layer interposed between a porous radiation-blocking layer and a radiation-transmissive reagent layer. All three layers are permeable to the analyte of interest.
  • the migration-inhibiting layer acts solely to reduce the migration of the detectable species back into the radiation-blocking layer where it would be undetectable. That is, it functions as a one-way valve.
  • the device consists of at least two layers, an immunosorbing zone and a liquid absorbing zone in liquid-receiving relationship. Additional layers can be involved which serve as barriers to inhibit migration of components of the signal producing system from the lower to the upper layer.
  • the barrier is a chemical or enzymatic barrier and its structural integrity is not breached in the course of the assay.
  • One of the layers can be a timing layer, the function of which is to retain a sample solution in the reaction layer for a time sufficient to allow complete reaction of the sample with the detection reagents.
  • the timing layer is typically composed of a polymeric material, preferably gelatin. It does not function as an all-or-none barrier to liquid flow, but merely controls the rate of that flow.
  • the multi-layered test devices described above share a common deficiency: Once the test sample is applied, the migration of analyte, reagents and reaction products becomes uncontrollable.
  • the ability to migrate as well as the rate of migration are functions of the structure of the device. There is no way to (1) stop the migration of a particular species within a preselected layer of the device for the purpose of increasing the reaction time within that particular layer and (2) restart the migration into subsequent layers.
  • the present invention is an improved multilayered test device for the analysis of analytes in test liquids.
  • the improved device comprises at least two liquid permeable functional layers separated by a barrier layer comprising a chemically inert, liquid insoluble, foraminous septum, the foramina of which are filled with a thermally sensitive material which is liquid impermeable at assay temperature, but capable of melting when heated, thereby providing rapid liquid communication between said functional layers.
  • the multilayer device of this invention consists of combinations of two types of layers, functional and barrier layers. Each device will contain at least two functional layers and at least one barrier layer.
  • the barrier layer is used to separate physically two functional layers and to inhibit liquid communication between them until heat is applied to the barrier layer.
  • the initial structural integrity of the barrier layer provides initial impermeability to fluid flow, but after application of heat and resultant loss of structural integrity of the barrier layer, liquid communication is provided between the functional layers.
  • the functional layers can perform one or more of the following functions: distribution, separation, reaction, detection, shielding and incubation. At least two such layers, separated by the barrier layer, are present in the device of this invention. Various combinations of two or more of these functional layers, with or without additional barrier layers, can be constructed.
  • the reaction functional layer contains reagents for interaction with test sample components. Incubation of reagents in the reaction layer for a predetermined time (greater than that provided by diffusion) can be controlled by a properly timed application of heat to the thermally sensitive material in the barrier layer.
  • the reaction layer is often used in conjunction with other functional layers. For example, enzyme immunoassays require an analyte-enzyme or an antibody-enzyme conjugate to be in a reaction layer. Upon application of the test sample, the analyte-enzyme conjugate (now a soluble reagent) and the free analyte from the test sample mix and compete for binding sites on an immobilized anti-analyte antibody.
  • the first functional layer combines, in principle, both the reaction and separation functions.
  • the subsequent layer can be a distribution layer which will also serve as a reaction and detection layer with reagents for the detection of the quantity of analyte-enzyme conjugate which permeates therein.
  • Reagents in the functional layers can be either soluble or immobilized.
  • the detection layer (sometimes referred to as a registration layer) can perform several functions.
  • the detection layer serves as the ultimate source for the detection of the analyte of interest.
  • the detection layer can be a separate layer or it can be combined with the reaction or incubation layer. It can contain reagents necessary for the formation of a detectable signal or it can serve to concentrate the signal.
  • the detection layer can also perform shielding functions.
  • the detection layer which is usually the bottommost functional layer of the device, can be permanently affixed to the test device or can be strippable from the device. If it is strippable, it can serve as a permanent record of the test result.
  • the detection process may involve the visual observation of test sample components (e.g., red blood cells) or the visual or instrumental detection of products of an enzymatic or other chemical reaction.
  • Other detection schemes include the visual or instrumental observation of aggregated latex particles or of colored pigment particles.
  • various instrumental means exist to detect the products of an enzymatic reaction, the analyte, or of various reaction products of the analyte. Often, a color will result which can be measured photometrically or reflectometrically.
  • the products could be measured by their light scattering properties using turbidimetric or nephelometric techniques. Fluorescent products can be easily detected either visually or by use of instrumentation.
  • the detection layer could also provide for the measurement of product through electrochemical means.
  • Ion-selective electrodes can be used and are well known in the art for the measurement of ionic species.
  • Amperometric detectors can be used for the detection of species such as H 2 0 2 and for the detection of a wide variety of analytes which are capable of producing H 2 0 2 when reacted with appropriate reagents.
  • the distribution layer when present, can serve several purposes: It distributes the sample fluid uniformly across the surface area of the test device. It determines, by virtue of its thickness, the volume of sample fluid which is imbibed. And it can function to concentrate the analyte and remove interfering substances.
  • a variety of paper and polymeric materials are suitable for fabrication of the distribution layer.
  • the separation functional layer serves to separate reagents and/or analyte during the performance of the test.
  • a separation layer is a controlled pore, size-exclusion gel layer which would separate materials, perhaps proteins from the test sample, on the basis of their molecular weight.
  • Another example is the use of a separation layer with immobilized antibody or antigen to bind antigen or antibody respectively. After barrier layer destruction, these bound molecules would be separated from the other components in the sample which can then migrate into a subsequent layer.
  • the incubation layer when present, functions as a holding zone. It may additionally contain immobilized or soluble reagents, in which case it also serves as a reaction layer.
  • the incubation layer can also function as a reservoir for excess liquid.
  • the shielding layer when present, functions to filter electromagnetic radiation. Most often this function is embodied in the support or base and does not constitute a separate layer.
  • the barrier layer serves to physically separate two functional layers and to prevent fluid communication between them until application of heat thereto.
  • the barrier layer should act as an all-or-none barrier to fluid flow.
  • assay temperature generally room temperature
  • the barrier layer of this invention can be made from a chemically inert, liquid insoluble, foraminous septum, the foramina of which are filled with a thermally sensitive material which is liquid impermeable at assay temperature, but capable of melting when heated above assay temperature.
  • the melting process can include other phenomena such as solvation and swelling which tend to produce a physical change in the material leading to an opening of the foramina to fluid flow.
  • the barrier layer is designed such that at least about a 5°C increase in temperature is required for melting. An increase of at least about 10°C is preferred. The exact amount of heat required will depend on the exact nature of the barrier layer as well as assay material constraints.
  • Filtration materials are generally the most useful but not exclusively the only types of materials which can be used for the septum. These types of materials generally have well defined flow characteristics and low nonspecific binding properties. Filtration materials also are readily available. Furthermore, once the foramina have been opened, the sieving filtration properties of the filter can be used to advantage in some instances to remove interfering test substances and/or separate "free" and "bound” test materials such as encountered in immunoassay applications.
  • filter support matrices there are four types which have been found useful.
  • the simplest types are constructed of net or woven materials such as nylon, synthetic polyester and natural fiber cloths. These materials generally have high strength and large pore sizes 50-1000 ⁇ , enabling the passage of large cells, and particulate solid phase reagents.
  • a second type of porous matrix which can be used are "depth filters”. These are constructed of fibrous sheets or mats made of randomly arrayed fibers. These types of materials create a tortuous path which are useful in presenting high surface area and entrapping large particles down to 10u.
  • Such supports have been constructed of fibers of glass, paper, fur, silk, wool, hemp, jute, linen, metal, nylon, polyester, cellulose acetate, quartz and rubber materials.
  • a third type of matrix are the microporous membrane filters which have quite complex, open, colloidal type structures. These are made of various colloidal polymer films and are commercially available from a variety of manufacturers. Most of the particle separations using the colloidal membrane filter matrices occur at the surface and not in the labyrinth of the internal channels. In some instances this presents an advantage since the solid phase can remain unincumbered by interfering particulates. However, colloidal membrane supports have relatively slow diffusion rates and for this reason are less preferred.
  • the fourth and most preferred type of matrix is a uniform pore membrane prepared from etching polycarbonate films with nuclear radiation.
  • These supports which are almost ideal sieves, have a true pore-like structure. These materials have very small void volumes. Impregnation thus forms a more secure fluid barrier. The membranes can thus be reduced in thickness without compromising the barrier properties.
  • the uniform pore supports have intermediate flow properties which can be controlled to some extent by varying the pore diameter. For barrier applications, pore diameters in the range of 0.5 to 20u are preferred.
  • a further advantage of these types of supports is that minimal liquid is trapped within the void volume of the support and thus lost or not easily recovered. Furthermore these supports are commercially available with pore densities of 10 8 to 10 9 cm. This is adequate to permit rapid fluid communication through the barrier layer.
  • the porous support matrix could be made to fulfill other important and essential test functions. These include (1) acting as a solid phase support for covalent or adsorbed test reagents: (2) acting as a "mordant sink" for the ionic or hydrophobic attachment of reaction materials (In this way, assay materials too small for filtration can be removed from the reaction mixture as it passes from one compartment to the next. In other words, by appropriate control over the chemical properties of the support, ionic and hydrophobic materials can be selectively removed from the test fluid as it passes from one compartment to the next. For example color dyes or interfering materials could be removed and prevented from entering the lower reaction compartments.): (3) sieving out or removing interfering particulates, cells or debris; (4) adjusting the flow rate between the layers.
  • thermally sensitive materials can be used for impregnation of the foraminous support in barrier layer preparation.
  • Materials possessing a high degree of crystalline structure at room temperature, exhibiting a low melt index and not readily dissolvable by aqueous solution while in the crystalline state, but readily soluble in the unfolded or disassociated state are ideal materials.
  • septum material affects the temperature at which melting, and therefore permeability, occurs.
  • a nylon mesh impregnated with 5% gelatin became permeable at approximately 30°C
  • filter paper impregnated with 5% gelatin became permeable at approximately 40°C.
  • a solution of the polymer is made by dissolving the polymer in a liquid solvent such as phosphate buffered saline (PBS).
  • PBS phosphate buffered saline
  • the septum is dipped into the solution and then allowed to dry. This causes the foramina of the septum to become clogged, thereby rendering the septum liquid impermeable.
  • the barrier layer is sandwiched generally contiguously between two functional layers.
  • a preferred way of sandwiching the barrier layer between two functional layers is as follows: Two thin solid frames having cut-out sections in them, generally circular, are placed on top of one another with the barrier layer sandwiched between them and the cut-outs aligned. The assembly can be clamped together or adhesive can be used on the face of the two frames which contact the barrier layer.
  • Absorbent material in the shape of the cut-out sections of the frame can be inserted within the cut-out sections to serve as functional layers.
  • the assembly is then placed on a solid support to complete the test device.
  • Application of heat to the barrier layer for example by placing the test device on a constant temperature surface, causes the hardened polymer to melt, thereby opening the foramina to fluid flow.
  • the foraminous nature of the septum can also serve to entrap the melted polymer thereby preventing occlusion of subsequent functional layers.
  • the foraminous nature of the septum once the polymer has been melted, causes capillary attraction of the test liquid through the septum and into the subsequent functional layer. The capillary attraction will allow the continued permeation of liquid independent of the direction of gravity.
  • the barrier and functional layers of the test device of this invention are generally disposed on a support layer which is impervious to fluid flow.
  • the support layer can also serve such additional functions as facilitating handling and radiation shielding. It can be bonded to the device or strippable therefrom and it can be fabricated with or without entry ports.
  • suitable support materials are Mylare, ceramic, and alumina.
  • a 5% w/v solution of Roselott gelatin was prepared in PBS by heating. The solution was maintained at a temperature of approximately 15°C above the solidification point. Samples of porous polycarbonate film, filter paper and nylon woven mesh were impregnated with the gelatin solution.
  • the polycarbonate film was obtained from Bio-Rad Laboratories as an 8y pore membrane sheet.
  • the supports were soaked until saturated with the gelatin solution and then removed and dried at room temperature for 4 hours. At this stage the supports were ready for use.
  • the layers were then placed on a surface maintained at 60°C. The time required for the fluid to penetrate into the lower layer was determined. After 53 seconds of heating, the dye migrated through the polycarbonate barrier layer. After 1.2 minutes of heating, the dye migrated through the nylon barrier layer. After 5 minutes of heating, the dye migrated through the paper barrier layer.
  • the temperature of the barrier layers was determined as a function of time. After about 1 minute of heating using the 60°C surface, the temperature of the barrier layer was roughly 33°C, while after 4 minutes, the temperature was roughly 45°C. This shows that the temperature to which the barrier layer must be raised to induce permeability is a function of the combination of the septum material and the thermally sensitive material.
  • test device was assembled from the following:
  • a diluted sample (100uL) of red blood cells (6% suspension in PBS buffer) was added to the anti-A layer. An additional 100 ⁇ L of PBS buffer was then added. Following 10 minutes of equilibration, the device was warmed at 48°C to open the barrier layer. The red cells not adsorbed to the top layer quickly passed into the lower chamber.
  • Polyamide mesh discs (3/4 x .002") were treated first with aqueous methanol containing 10% w/v CaCl 2 and then treated with 3.65 M HC1 for 30 minutes at 45°C. This hydrolyzed the polymer backbone and provided functional groups (COOH and NH 2 ) on the film surface for protein attachment. The film surface was then activated with a freshly prepared 5% aqueous solution of the trifunctional aziridine crosslinking reagent XAMA-7 (Cordova Chemical Co.) for 25 minutes at room temperature. Excess XAMA-7 reagent was removed by successive washes with purified water.
  • XAMA-7 trifunctional aziridine crosslinking reagent
  • Protein attachment was then achieved by equilibrating the activated nylon discs in a saline (0.85%) solution containing 2 mg/mL anti-horseradish peroxidase antisera (Cappel Laboratories). (Rabbit IgG was used as control.) The films were then washed free of excess protein in cold phosphate-buffered saline (PBS) buffer, pH 7.5, and stored at 4°C in PBS buffer until ready for use.
  • PBS cold phosphate-buffered saline
  • the barrier layer was prepared by impregnating the polycarbonate molecular filter (8.0u, Bio Rad) with 5% aqueous Roselott gelatin as described above.
  • the signal generating layers were prepared by saturating Whatman 54 filter paper discs with concentrated solutions containing o-phenylenediamine dihydrochloride and urea peroxide (25mg) in bicarbonate buffer pH 5.0 (5.0 mL). The discs were quickly frozen at -40°C and lyophilized.
  • the test device was assembled as follows: Rectangular frames were prepared by first cutting a 3/4" diameter hole in a plastic polyester sheet. Various thickness sheets were used depending on the reaction volume required for the test. The plastic layers were held together using double sided adhesive.
  • test sample was prepared by diluting 1.1 mg of purified horseradish peroxidase in 100 mL of PBS buffer (.01M. pH 7.4). Serial dilutions were then made in PBS buffer containing 0.8% (by weight) bovine serum albumin until a concentration of 1.1 ng/ml was prepared. 100 ⁇ L of this solution was then applied to each test element and equilibrated for 30 minutes at room temperature.
  • test element was warmed to 48°C at which time the barrier layer became permeable and rapid fluid migration occurred.
  • PBS buffer 200 ⁇ L was added to wash any residual "free" tag into the detection area and to solubilize the detection reagents. After five minutes of equilibration at room temperature the enzymatic chromogen development was visually observed through the bottom of the device.
  • the first detection unit was removed.
  • a second detection unit was attached.
  • Chromogen substrate solution 100 ⁇ L was added and the system equilibrated for five minutes.
  • the barrier layer was opened as described above and response visualized through the support film.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP84109420A 1983-08-10 1984-08-08 Mehrschichtteststreifen zur Bestimmung von Analyten in flüssigen Testproben Withdrawn EP0133700A3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/521,687 US4522786A (en) 1983-08-10 1983-08-10 Multilayered test device for detecting analytes in liquid test samples
US521687 1983-08-10

Publications (2)

Publication Number Publication Date
EP0133700A2 true EP0133700A2 (de) 1985-03-06
EP0133700A3 EP0133700A3 (de) 1987-10-28

Family

ID=24077716

Family Applications (1)

Application Number Title Priority Date Filing Date
EP84109420A Withdrawn EP0133700A3 (de) 1983-08-10 1984-08-08 Mehrschichtteststreifen zur Bestimmung von Analyten in flüssigen Testproben

Country Status (4)

Country Link
US (1) US4522786A (de)
EP (1) EP0133700A3 (de)
JP (1) JPS6058554A (de)
CA (1) CA1217699A (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989003039A1 (fr) * 1987-10-05 1989-04-06 S.A.R.L. Cis-Test Dispositif de detection immunoenzymatique
WO1989010564A1 (fr) * 1988-04-28 1989-11-02 Cis Bio International Dispositif et procede pour la determination qualitative et quantitative rapide de la presence d'un ligand reactif dans un fluide

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8522834D0 (en) * 1985-09-16 1985-10-23 Ici Plc Sensor
WO1989005978A1 (en) * 1987-12-14 1989-06-29 Liotta Lance A Layered immunoassay device containing fluid flow barrier
DE69131891T2 (de) * 1990-02-16 2000-06-15 F. Hoffmann-La Roche Ag, Basel Verbesserungen in der spezifität und zweckmässigkeit der polymerase-kettenreaktion
US5565339A (en) * 1992-10-08 1996-10-15 Hoffmann-La Roche Inc. Compositions and methods for inhibiting dimerization of primers during storage of polymerase chain reaction reagents
US5766552A (en) * 1993-04-20 1998-06-16 Actimed Laboratories, Inc. Apparatus for red blood cell separation
US5660798A (en) * 1993-04-20 1997-08-26 Actimed Laboratories, Inc. Apparatus for red blood cell separation
US5447689A (en) * 1994-03-01 1995-09-05 Actimed Laboratories, Inc. Method and apparatus for flow control
US6048734A (en) * 1995-09-15 2000-04-11 The Regents Of The University Of Michigan Thermal microvalves in a fluid flow method
US6911183B1 (en) 1995-09-15 2005-06-28 The Regents Of The University Of Michigan Moving microdroplets
US6130098A (en) * 1995-09-15 2000-10-10 The Regents Of The University Of Michigan Moving microdroplets
US6692700B2 (en) 2001-02-14 2004-02-17 Handylab, Inc. Heat-reduction methods and systems related to microfluidic devices
US7010391B2 (en) 2001-03-28 2006-03-07 Handylab, Inc. Methods and systems for control of microfluidic devices
US7829025B2 (en) 2001-03-28 2010-11-09 Venture Lending & Leasing Iv, Inc. Systems and methods for thermal actuation of microfluidic devices
US6852287B2 (en) * 2001-09-12 2005-02-08 Handylab, Inc. Microfluidic devices having a reduced number of input and output connections
US8895311B1 (en) 2001-03-28 2014-11-25 Handylab, Inc. Methods and systems for control of general purpose microfluidic devices
US7323140B2 (en) 2001-03-28 2008-01-29 Handylab, Inc. Moving microdroplets in a microfluidic device
JP4996248B2 (ja) 2003-07-31 2012-08-08 ハンディーラブ インコーポレイテッド 粒子含有サンプルの処理
DE10350880A1 (de) * 2003-10-31 2005-06-02 Roche Diagnostics Gmbh Verfahren zur Bestimmung eines Analyten mittels einer Extraktionsschicht
US8852862B2 (en) 2004-05-03 2014-10-07 Handylab, Inc. Method for processing polynucleotide-containing samples
EP2345739B8 (de) 2004-05-03 2016-12-07 Handylab, Inc. Mikrofluidische Vorrichtung zur Verarbeitung polynukleotidhaltiger Proben
US20060183216A1 (en) * 2005-01-21 2006-08-17 Kalyan Handique Containers for liquid storage and delivery with application to microfluidic devices
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
WO2006098804A2 (en) 2005-03-11 2006-09-21 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
US8936945B2 (en) * 2005-11-17 2015-01-20 The Regents Of The University Of Michigan Compositions and methods for liquid metering in microchannels
US11806718B2 (en) 2006-03-24 2023-11-07 Handylab, Inc. Fluorescence detector for microfluidic diagnostic system
US10900066B2 (en) 2006-03-24 2021-01-26 Handylab, Inc. Microfluidic system for amplifying and detecting polynucleotides in parallel
US7998708B2 (en) 2006-03-24 2011-08-16 Handylab, Inc. Microfluidic system for amplifying and detecting polynucleotides in parallel
US8883490B2 (en) 2006-03-24 2014-11-11 Handylab, Inc. Fluorescence detector for microfluidic diagnostic system
US8088616B2 (en) 2006-03-24 2012-01-03 Handylab, Inc. Heater unit for microfluidic diagnostic system
WO2007112114A2 (en) 2006-03-24 2007-10-04 Handylab, Inc. Integrated system for processing microfluidic samples, and method of using same
US8709787B2 (en) 2006-11-14 2014-04-29 Handylab, Inc. Microfluidic cartridge and method of using same
US9186677B2 (en) 2007-07-13 2015-11-17 Handylab, Inc. Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
US9618139B2 (en) 2007-07-13 2017-04-11 Handylab, Inc. Integrated heater and magnetic separator
US8105783B2 (en) 2007-07-13 2012-01-31 Handylab, Inc. Microfluidic cartridge
USD621060S1 (en) 2008-07-14 2010-08-03 Handylab, Inc. Microfluidic cartridge
WO2009012185A1 (en) 2007-07-13 2009-01-22 Handylab, Inc. Polynucleotide capture materials, and methods of using same
US8287820B2 (en) 2007-07-13 2012-10-16 Handylab, Inc. Automated pipetting apparatus having a combined liquid pump and pipette head system
US8182763B2 (en) 2007-07-13 2012-05-22 Handylab, Inc. Rack for sample tubes and reagent holders
US20090136385A1 (en) 2007-07-13 2009-05-28 Handylab, Inc. Reagent Tube
US8133671B2 (en) 2007-07-13 2012-03-13 Handylab, Inc. Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
US8381169B2 (en) * 2007-10-30 2013-02-19 International Business Machines Corporation Extending unified process and method content to include dynamic and collaborative content
USD618820S1 (en) 2008-07-11 2010-06-29 Handylab, Inc. Reagent holder
USD787087S1 (en) 2008-07-14 2017-05-16 Handylab, Inc. Housing
US20100022916A1 (en) 2008-07-24 2010-01-28 Javanbakhsh Esfandiari Method and Apparatus for Collecting and Preparing Biological Samples for Testing
US8603835B2 (en) 2011-02-10 2013-12-10 Chembio Diagnostic Systems, Inc. Reduced step dual path immunoassay device and method
AU2012242510B2 (en) 2011-04-15 2015-05-14 Becton, Dickinson And Company Scanning real-time microfluidic thermocycler and methods for synchronized thermocycling and scanning optical detection
US20140170735A1 (en) 2011-09-25 2014-06-19 Elizabeth A. Holmes Systems and methods for multi-analysis
US9664702B2 (en) 2011-09-25 2017-05-30 Theranos, Inc. Fluid handling apparatus and configurations
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US8475739B2 (en) 2011-09-25 2013-07-02 Theranos, Inc. Systems and methods for fluid handling
US9810704B2 (en) 2013-02-18 2017-11-07 Theranos, Inc. Systems and methods for multi-analysis
US10012664B2 (en) 2011-09-25 2018-07-03 Theranos Ip Company, Llc Systems and methods for fluid and component handling
JP6117217B2 (ja) 2011-09-30 2017-04-19 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company ユニット化された試薬ストリップ
USD692162S1 (en) 2011-09-30 2013-10-22 Becton, Dickinson And Company Single piece reagent holder
EP2773892B1 (de) 2011-11-04 2020-10-07 Handylab, Inc. Vorrichtung zur vorbereitung von polynukleotidproben
ES2978107T3 (es) 2012-02-03 2024-09-05 Becton Dickinson Co Archivos externos para distribución de pruebas de diagnóstico molecular y determinación de compatibilidad entre pruebas
US10359380B2 (en) 2014-02-25 2019-07-23 C.Y. O'connor Erade Village Foundation Inc. Methods and systems for measuring melting temperatures
CN106574223B (zh) 2014-04-02 2019-11-01 生化诊断系统公司 利用俘获缀合物的免疫测定
US20160116466A1 (en) 2014-10-27 2016-04-28 Chembio Diagnostic Systems, Inc. Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses
CN111272990B (zh) * 2020-02-27 2025-03-07 民康医疗科技(天津)有限公司 一种干化学检测试纸及制备工艺

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL129843C (de) * 1965-05-20
US3420205A (en) * 1966-03-23 1969-01-07 Miles Lab Indicating device
US3723064A (en) * 1971-07-26 1973-03-27 L Liotta Method and device for determining the concentration of a material in a liquid
DE2332760C3 (de) * 1972-06-30 1982-03-04 Eastman Kodak Co., 14650 Rochester, N.Y. Material für die quantitative spektrophotometrische Analyse einer Flüssigkeit
US3992158A (en) * 1973-08-16 1976-11-16 Eastman Kodak Company Integral analytical element
US4042335A (en) * 1975-07-23 1977-08-16 Eastman Kodak Company Integral element for analysis of liquids
CA1095819A (en) * 1977-01-14 1981-02-17 Eastman Kodak Company Element for analysis of liquids
US4166093A (en) * 1977-08-08 1979-08-28 Eastman Kodak Company Reduction of detectable species migration in elements for the analysis of liquids
US4160008A (en) * 1978-01-26 1979-07-03 Miles Laboratories, Inc. Multilayered test device for determining the presence of a liquid sample component, and method of use
US4258001A (en) * 1978-12-27 1981-03-24 Eastman Kodak Company Element, structure and method for the analysis or transport of liquids
US4288228A (en) * 1979-01-31 1981-09-08 Technicon Instruments Corporation Whole blood analyses and diffusion apparatus therefor
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
JPS57200862A (en) * 1981-06-05 1982-12-09 Fuji Photo Film Co Ltd Mutilayer analysis element utilizing unique binding reaction
JPS60222769A (ja) * 1984-04-19 1985-11-07 Fuji Photo Film Co Ltd 一体型多層分析要素

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989003039A1 (fr) * 1987-10-05 1989-04-06 S.A.R.L. Cis-Test Dispositif de detection immunoenzymatique
EP0334947A1 (de) * 1987-10-05 1989-10-04 Quick - Test Immunoenzymatisches testgerät
US5783401A (en) * 1987-10-05 1998-07-21 Quidel Corporation Immunoenzymatic detection device
WO1989010564A1 (fr) * 1988-04-28 1989-11-02 Cis Bio International Dispositif et procede pour la determination qualitative et quantitative rapide de la presence d'un ligand reactif dans un fluide
FR2630827A1 (fr) * 1988-04-28 1989-11-03 Oris Ind Dispositif et procede pour la determination qualitative et quantitative rapide de la presence d'un ligand reactif dans un fluide

Also Published As

Publication number Publication date
EP0133700A3 (de) 1987-10-28
CA1217699A (en) 1987-02-10
JPS6058554A (ja) 1985-04-04
US4522786A (en) 1985-06-11
JPH0453262B2 (de) 1992-08-26

Similar Documents

Publication Publication Date Title
US4522786A (en) Multilayered test device for detecting analytes in liquid test samples
US4851210A (en) Blood typing device
EP0051183B1 (de) Mehrschichtiges analytisches Element
US5827749A (en) Ligand assay method
EP0560411B1 (de) Spezifische Bindungstestverfahren
US5981294A (en) Device for blood separation in a diagnostic device
US5185127A (en) Test device including flow control means
US4956302A (en) Lateral flow chromatographic binding assay device
EP0306772B1 (de) Gerät für die laterale immunochromatographische Bestimmung
JP5181058B2 (ja) ヒトabo/rh/mn血液型を迅速に判定する方法及びキット
JP2940990B2 (ja) 全血からの血漿または血清の分離装置および方法
US4965187A (en) Method and apparatus for assaying whole blood
CA2048530A1 (en) Membranes and membrane overlays for exclusion of erythrocytes for solid state assays
JPH03118473A (ja) 流量調整手段を含む試験装置
WO1996035123A1 (en) Diagnostic detection device and method
EP1064553A1 (de) Gerät und methode für immunoassays
JP2010531989A (ja) 血液型の識別と特定の方式および装置
JPS63502139A (ja) 生物学的診断装置
JPH08285849A (ja) 簡易測定装置およびこれを用いる測定方法
JP4426122B2 (ja) 血中抗原検出方法及び装置
US20030013206A1 (en) Chromatorgraphy measuring instrument
JPH0972905A (ja) 微量なヘモグロビン▲A1c▼測定用乾式試験具

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19871222

17Q First examination report despatched

Effective date: 19890328

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19890809

R18W Application withdrawn (corrected)

Effective date: 19890809

RIN1 Information on inventor provided before grant (corrected)

Inventor name: EBERSOLE, RICHARD CALVIN